Skip to content
value.today

Amphivena Therapeutics, Inc.

Formerly Affimed Spinco Inc.

Total raised
$65 M
3 rounds on record
Latest round
$39 M
Dec 2018
First round on record
Jul 2013
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Amphivena Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2018$39 MNo. 3$10 to $50 million

Amphivena Therapeutics, Inc.: Raise no. 3, Dec 2018

Investors in this round

15 investors had bought by the notice of Dec 19, 2018: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$39 M of $50 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeanmarie Guenot · Executive Officer, Director
  • Peter Van Vasselaer · Executive Officer, Director
  • Christian Richard · Director
  • Eric Moessinger · Director
  • Luke Evnin · Director
  • Mark McDade · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeanmarie Guenot, President. Source: SEC Form D, newest notice filed Dec 19, 2018. Read the notice at the SEC.

equitySEC
Jul 2017$7 MNo. 2$2 to $10 million

Amphivena Therapeutics, Inc.: Raise no. 2, Jul 2017

Investors in this round

2 investors had bought by the notice of Jul 26, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeanmarie Guenot · Executive Officer, Director
  • Christian Richard · Director
  • Florian Fischer · Director
  • Luke Evnin · Director
  • Vinay Bhaskar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeanmarie Guenot, President. Source: SEC Form D, newest notice filed Jul 26, 2017. Read the notice at the SEC.

equitySEC
Jul 2013$20 MNo. 1$10 to $50 million

Amphivena Therapeutics, Inc.: Raise no. 1, Jul 2013

Investors in this round

4 investors had bought by the notice of Jun 26, 2017: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeanmarie Guenot · Executive Officer, Director
  • Florian Fischer · Director
  • Luke Evnin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeanmarie Guenot, President. Source: SEC Form D and 2 amendments, newest notice filed Jun 26, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Amphivena Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2018).

    SEC Form D · Dec 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2018

That is all the official record says: Amphivena Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Amphivena Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Amphivena Therapeutics, Inc.
NameRoleNamed in
Jeanmarie GuenotExecutive officerDec 2018
Peter Van VasselaerExecutive officerDec 2018
Christian RichardDirectorDec 2018
Eric MoessingerDirectorDec 2018
Jeanmarie GuenotDirectorDec 2018
Luke EvninDirectorDec 2018
Mark McDadeDirectorDec 2018
Peter Van VasselaerDirectorDec 2018
Florian FischerDirectorJul 2017
Vinay BhaskarDirectorJul 2017
Adi HoessDirectorMay 2015
Frank MuhlenbeckDirectorMay 2015
Phil GutryDirectorMay 2015